SEC Form 424B5 filed by Can-Fite Biopharma Ltd Sponsored ADR (Israel) - Quantisnow

Retrieved on: 2025-05-09 20:35:02

Tags for this article:

Initial public offering

Financial markets

Corporate finance

Prospectus

Forward-looking statement

U.S. Securities and Exchange Commission

Shelf registration

Public offering

American depositary receipt

Registration statement

Red herring prospectus

Click the tags to see associated articles and topics

SEC Form 424B5 filed by Can-Fite Biopharma Ltd Sponsored ADR (Israel) - Quantisnow. View article details on hiswai:

Summary

The article discusses a prospectus supplement for Can-Fite BioPharma Ltd.'s American Depositary Shares offering, fitting into the design of financial markets through IPO procedures regulated by entities like the U.S. SEC.

Article found on: quantisnow.com

View Original Article